Skip to main content

GENERAL COMMENTARY article

Front. Endocrinol.
Sec. Clinical Diabetes
Volume 15 - 2024 | doi: 10.3389/fendo.2024.1445226
This article is part of the Research Topic Strategies to Overcome Metabolic Syndrome and Related Diseases View all 13 articles

Commentary: A Rapid Action Plan to Improve Diagnosis and Management of Lipodystrophy

Provisionally accepted
William J. Massey William J. Massey 1*Lin Zhu Lin Zhu 2*
  • 1 Lerner Research Institute, Cleveland Clinic, Cleveland, Ohio, United States
  • 2 Vanderbilt University Medical Center, Nashville, United States

This article is a commentary on:

  1. A rapid action plan to improve diagnosis and management of lipodystrophy syndromes

    1. Read original article

The final, formatted version of the article will be published soon.

    Keywords: Lipodystrophy syndromes, Adipose Tissue, Concomitant disease, Rare endocrine disorders, metabolic disease, diabetic obesity

    Received: 07 Jun 2024; Accepted: 26 Aug 2024.

    Copyright: © 2024 Massey and Zhu. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

    * Correspondence:
    William J. Massey, Lerner Research Institute, Cleveland Clinic, Cleveland, 44195, Ohio, United States
    Lin Zhu, Vanderbilt University Medical Center, Nashville, United States

    Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.